acetyl-l-carnitine tnation 1000 mg Acetyl-L-Carnitine 500 mg

FIGURE 3 3.1.2 Deoxycytidine derivant: Decitabine Decitabine ( 2 ) was approved by the FDA in 2006 for the treatment of MDS with a trade name of Dacogen (Center for Drug Evaluation and Research)

To explore the effects of the rec-ECM1 protein on liver fibrosis, we built a CCl 4 -induced liver fibrosis mice model based on the methodology outlined in a prior study [20], followed by treatment with two different doses (50 g/Kg or 150 g/Kg) of rec-ECM1 administered biweekly, along with the continuous administration of CCl 4 (Additional File 3 Fig

10.1038/s41390-019-0728-6 248 WilckenD

Caricato, M

GABA Synthesis, Signaling, and Transportation